These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2337671)

  • 1. Tumor necrosis factor-alpha exhibits greater proinflammatory activity than lymphotoxin in vitro.
    Desch CE; Dobrina A; Aggarwal BB; Harlan JM
    Blood; 1990 May; 75(10):2030-4. PubMed ID: 2337671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC; Harlan JM; Adamson JW
    J Immunol; 1987 Jun; 138(12):4298-302. PubMed ID: 3495589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells.
    Pober JS
    Ciba Found Symp; 1987; 131():170-84. PubMed ID: 3330009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human tumor necrosis factor alpha, lymphotoxin, and Escherichia coli lipopolysaccharide on hemodynamics, lung microvascular permeability, and eicosanoid synthesis in anesthetized sheep.
    Kreil EA; Greene E; Fitzgibbon C; Robinson DR; Zapol WM
    Circ Res; 1989 Aug; 65(2):502-14. PubMed ID: 2665972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by IL-1 of endothelial cell activation induced by tumor necrosis factor or lymphotoxin.
    Cavender DE; Edelbaum D
    J Immunol; 1988 Nov; 141(9):3111-6. PubMed ID: 2459241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell activation induced by tumor necrosis factor and lymphotoxin.
    Cavender DE; Edelbaum D; Ziff M
    Am J Pathol; 1989 Mar; 134(3):551-60. PubMed ID: 2466402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of interferon-gamma binding by tumor necrosis factor and lymphotoxin: disparate potencies of the cytokines and modulation of their effects by phorbol ester.
    Raitano AB; Scuderi P; Korc M
    J Interferon Res; 1991 Feb; 11(1):61-7. PubMed ID: 1903142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors.
    Kluge M; Elger B; Engel T; Schaefer C; Seega J; Vaupel P
    Cancer Res; 1992 Apr; 52(8):2167-73. PubMed ID: 1559220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
    Hochman PS; Majeau GR; Mackay F; Browning JL
    J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
    Pober JS; Lapierre LA; Stolpen AH; Brock TA; Springer TA; Fiers W; Bevilacqua MP; Mendrick DL; Gimbrone MA
    J Immunol; 1987 May; 138(10):3319-24. PubMed ID: 3494766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism.
    Pohlman TH; Stanness KA; Beatty PG; Ochs HD; Harlan JM
    J Immunol; 1986 Jun; 136(12):4548-53. PubMed ID: 3486903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in permeability of human endothelial cell monolayer by recombinant human lymphotoxin.
    Shinjo K; Tsuda S; Hayami T; Asahi T; Kawaharada H
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1431-7. PubMed ID: 2788411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response.
    Chaturvedi MM; LaPushin R; Aggarwal BB
    J Biol Chem; 1994 May; 269(20):14575-83. PubMed ID: 8182064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1.
    Bussolino F; Camussi G; Tetta C; Garbarino G; Bosia A; Baglioni C
    J Lipid Mediat; 1990; 2 Suppl():S15-22. PubMed ID: 2133280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts.
    Kurt-Jones EA; Fiers W; Pober JS
    J Immunol; 1987 Oct; 139(7):2317-24. PubMed ID: 3116078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis.
    Pohlman TH; Harlan JM
    Cell Immunol; 1989 Mar; 119(1):41-52. PubMed ID: 2784080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells.
    Carlos TM; Schwartz BR; Kovach NL; Yee E; Rosa M; Osborn L; Chi-Rosso G; Newman B; Lobb R
    Blood; 1990 Sep; 76(5):965-70. PubMed ID: 1697486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-beta) on a human histiocytic lymphoma cell line, U-937.
    Stauber GB; Aggarwal BB
    J Biol Chem; 1989 Feb; 264(6):3573-6. PubMed ID: 2536752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
    J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor.
    Warner SJ; Libby P
    J Immunol; 1989 Jan; 142(1):100-9. PubMed ID: 2783319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.